2004
DOI: 10.1016/j.healun.2003.07.005
|View full text |Cite
|
Sign up to set email alerts
|

How to predict forced vital capacity after living-donor lobar-lung transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
46
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
3

Relationship

4
4

Authors

Journals

citations
Cited by 45 publications
(49 citation statements)
references
References 16 publications
3
46
0
Order By: Relevance
“…7 Hence, large adult patients are believed to be poor candidates for LDLLT; NLSLT provides an opportunity for lung transplantation in such patients. As we previously reported that overall survival in patients having LDLLT reached 93.6%, 2 NLSLT is also expected to provide a survival benefit to patients.…”
Section: Discussionmentioning
confidence: 99%
“…7 Hence, large adult patients are believed to be poor candidates for LDLLT; NLSLT provides an opportunity for lung transplantation in such patients. As we previously reported that overall survival in patients having LDLLT reached 93.6%, 2 NLSLT is also expected to provide a survival benefit to patients.…”
Section: Discussionmentioning
confidence: 99%
“…We previously proposed a size-matching formula to estimate the graft forced vital capacity (FVC) based on the donor's measured FVC and the number of pulmonary segments implanted. 8 When the total FVC of the two grafts was greater than 45%-50% of the predicted FVC of the recipient, we accepted the size disparity, regardless of the recipient's diagnosis.…”
Section: Patient and Donor Selectionmentioning
confidence: 98%
“…Postoperative immunosuppression consisted of triple-drug therapy with cyclosporine or tacrolimus, azathioprine, or mycophenolate mofetil (MMF), and corticosteroids. 8 Induction cytolytic therapy was not used. We gave patients with infectious lung diseases, pediatric patients, and patients already receiving steroids a combination of cyclosporine, azathioprine, and steroids; and all others a combination of tacrolimus, MMF, and steroids.…”
Section: Postoperative Management Of the Recipientsmentioning
confidence: 99%
“…It allows us to perform more precise functional matching in LDLLT. For "functional size matching", we rely on graft FVC (4,21). We have made a formula for estimating the graft FVC based on the donor's measured FVC and the number of pulmonary segments implanted.…”
Section: Functional Size Matchingmentioning
confidence: 99%